| Bid Price | 0.41p | High Price | 0.44p |
|---|
| Ask Price | 0.45p | Low Price | 0.41p |
|---|
| Open Price | 0.46p | Spread | 8.89% |
|---|
| Prev Close | 0.46p | Volume | 942,827 |
|---|
Physiomics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Aug 4, 2025 | 0.46 | 0.44 | 0.41 | 0.43 | 942,827 |
| Aug 1, 2025 | 0.43 | 0.45 | 0.43 | 0.46 | 2,811,974 |
| Jul 31, 2025 | 0.47 | 0.50 | 0.42 | 0.43 | 3,391,527 |
| Jul 30, 2025 | 0.47 | 0.45 | 0.45 | 0.47 | 211,000 |
| Jul 29, 2025 | 0.47 | 0.45 | 0.45 | 0.47 | 250,000 |
Physiomics PLC Information
| Name | Physiomics PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BDR6W943 | Epic | PYC |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASX1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 500,000 | Trading Status | Closed |
|---|
| Shares in Issue | 303.21 m | Prev Close | 0.46p |
|---|
| PE Ratio | | Market Cap | £1.30 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.659503 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 4.773585 | Quick Ratio | 4.773585 |
|---|
Physiomics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 08/11/24 | BUY | Peter Sargent | CEO | 459,090 @ £0.01 | £3,030.00 |
| 25/07/23 | TOUT | James Millen | CEO | 500,000 @ £0.00 | £0.00 |
| 25/07/23 | TIN | James Millen | CEO | 500,000 @ £0.00 | £0.00 |
| 18/07/23 | TOUT | Christophe Chassagnole | RES | 500,000 @ £0.00 | £0.00 |
| 03/07/23 | PLAC | James Millen | CEO | 500,000 @ £0.00 | £500.00 |
| 22/03/21 | SELL | James Millen | CEO | 2,354 @ £0.00 | £0.00 |
| 22/03/21 | TOUT | James Millen | CEO | 242,287 @ £0.00 | £0.00 |
| 22/03/21 | TIN | James Millen | CEO | 242,287 @ £0.00 | £0.00 |
| 12/08/20 | SELL | James Millen | CEO | 597,332 @ £0.06 | £38,528.00 |
| 05/08/20 | EXR | James Millen | CEO | 1,453,923 @ £0.03 | £36,348.00 |
Physiomics PLC News
